These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 709096)

  • 1. Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.
    Pentikainen PJ; Neuvonen PJ; Tarpila S; Syvälahti E
    Br Med J; 1978 Sep; 2(6141):861-3. PubMed ID: 709096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.
    Pentikäinen PJ; Neuvonen PJ; Jostell KG
    Eur J Clin Pharmacol; 1980 Apr; 17(4):275-84. PubMed ID: 6995129
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of chlormethiazole in humans.
    Moore RG; Triggs EJ; Shanks CA; Thomas J
    Eur J Clin Pharmacol; 1975 Jun; 8(5):353-7. PubMed ID: 1233235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver.
    Pond SM; Tong T; Benowitz NL; Jacob P
    Aust N Z J Med; 1980 Oct; 10(5):515-9. PubMed ID: 6937164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.
    Rames A; Poirier JM; LeCoz F; Midavaine M; Lecocq B; Grange JD; Poupon R; Cheymol G; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):354-9. PubMed ID: 2178853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethanol administration on the disposition and elimination of chlormethiazole.
    Bury RW; Desmond PV; Mashford ML; Westwood B; Shaw G; Breen KJ
    Eur J Clin Pharmacol; 1983; 24(3):383-5. PubMed ID: 6861852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flumazenil disposition and elimination in cirrhosis.
    Janssen U; Walker S; Maier K; von Gaisberg U; Klotz U
    Clin Pharmacol Ther; 1989 Sep; 46(3):317-23. PubMed ID: 2505960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine impairs the elimination of chlormethiazole.
    Shaw G; Bury RW; Mashford ML; Breen KJ; Desmond PV
    Eur J Clin Pharmacol; 1981; 21(1):83-5. PubMed ID: 7333351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
    Magueur E; Hagege H; Attali P; Singlas E; Etienne JP; Taburet AM
    Br J Clin Pharmacol; 1991 Feb; 31(2):185-7. PubMed ID: 2049236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the psychometric effects of chlormethiazole in healthy young and elderly subjects.
    Fagan D; Lamont M; Jostell KG; Tiplady B; Scott DB
    Age Ageing; 1990 Nov; 19(6):395-402. PubMed ID: 2285007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability and pharmacodynamics of chlormethiazole in healthy young and elderly volunteers: preliminary findings.
    Jostell KG; Fagan D; Björk M; Broberg F; Mitchell RM; Scott DB; Ulff B
    Acta Psychiatr Scand Suppl; 1986; 329():32-3. PubMed ID: 3463155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects.
    Hall KW; Nightingale CH; Gibaldi M; Nelson E; Bates TR; DiSanto AR
    J Clin Pharmacol; 1982 Jul; 22(7):321-5. PubMed ID: 7107981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
    Vinçon G; Baldit C; Couzigou P; Demotes-Mainard F; Elouaer-Blanc L; Bannwarth B; Begaud B
    Eur J Clin Pharmacol; 1992; 43(5):559-62. PubMed ID: 1483496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of melatonin in man: first pass hepatic metabolism.
    Lane EA; Moss HB
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1214-6. PubMed ID: 4055987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects.
    Pond SM; Tong T; Benowitz NL; Jacob P; Rigod J
    Clin Pharmacol Ther; 1981 Aug; 30(2):183-8. PubMed ID: 7249503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of chlormethiazole following intravenous administration in the aged.
    Nation RL; Learoyd B; Barber J; Triggs EJ
    Eur J Clin Pharmacol; 1976; 10(6):407-15. PubMed ID: 1001356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.